Stress activates the nucleus incertus and modulates plasticity in the hippocampo-medial prefrontal cortical pathway  by Rajkumar, Ramamoorthy et al.
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The  nucleus  incertus  (NI)  is  a small  cluster  of  brainstem  neurons  presumed  to  play  a  role in  stress
responses.  We  show  that swim  stress  (normal  water:  30 min  and  cold  water:  20 min)  and  elevation
stress  robustly  induced  c-Fos  expression  in  the  NI and  signiﬁcantly  suppressed  long-term  potentiation
(LTP)  in the  hippocampo-medial  prefrontal  cortical  (HP-mPFC)  pathway.  To examine  whether  activation
of  CRF1 receptors  in  the  NI  plays  a role  in  the  suppression  of  HP-mPFC  LTP,  antalarmin,  a  speciﬁc  CRF1
receptor  antagonist,  was  infused  directly  into  the  NI  either  before  presentation  of (1)  elevation  stress  oreywords:
ucleus incertus
ippocampus
edial prefrontal cortex
tress
-Fos
lasticity
(2)  high  frequency  stimulation.  As  predicted,  the  intra-NI  infusion  of  antalarmin  reversed  the  elevation
stress-induced  suppression  of LTP  in  the HP-mPFC  pathway.  This  report  suggests  that  the  CRF1 receptor
in  the NI contributes  to  stress-related  impairment  in  plasticity  of  the  HP-mPFC  pathway.  The  ﬁndings
suggest  that  the  NI-HP-mPFC  is  a stress  responsive  circuit  in  the rodent  brain.
©  2015  The  Authors.  Published  by  Elsevier  Inc. This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).. Introduction
The nucleus incertus (NI) is a group of neurons in the caudal
art of mammalian brain stem. Corticotropin releasing factor type
 (CRF1) receptor expression in the NI not only deﬁnes the pre-
ise localisation of this neuronal group, but also hints at its role in
tress responses (Rivest et al., 1995; Tanaka et al., 2005). The NI,
part from being the principal source of relaxin-3 and the epicen-
re of the brain relaxinergic system, is GABAergic (Ma  et al., 2007)
n nature and expresses various neurotransmitters and peptides
for review see (Ryan et al., 2011)]. NI neurons respond to stress-
rs such as immobilisation or forced swimming as is evident from
levated c-Fos (Tanaka et al., 2005) and relaxin-3 mRNA (Banerjee
t al., 2010) expression, respectively. Recently, we  have shown that
RF1 receptor positive NI neurons project to the medial prefrontal
∗ Corresponding author at: Department of Pharmacology, Yong Loo Lin School
f Medicine, Building MD3, #04-01Y, 16 Medical Drive, National University of
ingapore, 117600, Singapore.
E-mail address: gavin dawe@nuhs.edu.sg (G.S. Dawe).
1 Current address: Interdepartmental Neuroscience Program, Yale University,
ew Haven, Connecticut, USA.
ttp://dx.doi.org/10.1016/j.brainresbull.2015.10.010
361-9230/© 2015 The Authors. Published by Elsevier Inc. This is an open access article ucortex (mPFC) and that infusion of CRF peptide (into the NI) or elec-
trical stimulation of the NI inhibits neuronal ﬁring in the medial
prefrontal cortex (mPFC) and impairs long-term potentiation (LTP)
in the hippocampo-medial prefrontal cortical (HP-mPFC) pathway
(Farooq et al., 2013). Furthermore, elevation stress is known to
impair LTP in the HP-mPFC pathway (Rocher et al., 2004). Here we
investigated the effects of stressors – cold water swim (20 min),
swim (30 min), and elevation (30 min) – on c-Fos expression in the
NI and LTP in the HP-mPFC pathway. In addition, the effect of infu-
sion of antalarmin, a selective CRF1 receptor antagonist (Webster
et al., 1996), into the NI (prior to presentation of stress or high fre-
quency stimulation) on the elevation stress-induced impairment of
HP-mPFC LTP was studied in order to elucidate the contribution of
the NI in stress-induced impairment of HP-mPFC LTP.
2. Experimental procedures
2.1. AnimalsAll procedures on animals were approved by the Institutional
Animal Care and Use Committee (IACUC), National University of
Singapore, and were carried out in accordance with the Guide-
lines on the Care and Use of Animals for Scientiﬁc Purposes
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
8 search Bulletin 120 (2016) 83–89
d
A
D
l
u
D
R
w
w
l
T
e
2
A
d
C
t
i
w
1
L
2
(
s
r
s
h
s
t
(
w
e
v
(
f
h
(
c
d
2
f
B
t
a
o
b
g
n
a
h
f
t
s
w
a
Fig. 1. Schematic representation of the study design. (A) Effects of different stressors
on c-Fos expression in the NI and HP-mPFC LTP were studied in separate groups of
rats. (B) Effects of intra-NI infusion of antalarmin were investigated prior to elevation
stress or prior to HFS (post elevation stress) on the HP-mPFC LTP. (C) Representative
micrograph of a brainstem section showing a Pontamine sky blue dye spot in the NI4 R. Rajkumar et al. / Brain Re
eveloped by the National Advisory Committee For Laboratory
nimal Research, Singapore; the European Communities Council
irective of 24 November 1986 (86/609/EEC); and the Guide-
ines laid down by the NIH in the US regarding the care and
se of animals for experimental procedures. Adult male Sprague-
awley rats (290–350 g) were obtained from the Centre for Animal
esources (CARE), National University of Singapore. Pairs of rats
ere housed in individually ventilated cages in a housing room that
as temperature-controlled (23 ± 1 ◦C) and maintained on a 12-h
ight–dark cycle (07:00–19:00 h) with free access to food and water.
hey were acclimatised for at least 3 days before the initiation of
xperiments.
.2. Drugs and chemicals
Ketamine (Parnell Manufacturing Pty Ltd; Alexandria, NSW,
ustralia), xylazine (Ilium Xylazil, Troy Laboratories Pty Ltd; Glen-
enning, NSW, Australia), enroﬂoxacin (Baytril 5%, Bayer Health
are; Seoul, Korea) and carprofen (Carprieve, Norbrook Labora-
ories (GB), Ltd; Carlisle, UK) were freshly prepared in sterile
sotonic saline before use. Antalarmin hydrochloride (Tocris, UK)
as dissolved in sterile 0.9% saline by sonication at 60 ◦C for
0–15 min. Pentobarbital (Valabarb) was purchased from Jurox Pty
td, Australia.
.3. Stress protocols
Rats were subjected to three kinds of stress protocols published
Rocher et al., 2004; Tan et al., 2004) elsewhere, and adopted with
light modiﬁcations as described below. In the cold swim stress,
ats were individually forced to swim for a duration of 20 min in a
emitransparent cylindrical plastic container (Diameter: 32 cm and
eight: 42 cm)  ﬁlled with water (18 ◦C) to a depth of 30 cm.  The
wim stress procedure was similar to the cold swim stress condi-
ion except for the duration (30 min) of stress and the temperature
24–25 ◦C) of water. After swim stress (either variants), the rats
ere dried with a towel and returned to their home cages. In the
levation stress protocol, the rats were placed on an unsteady ele-
ated (1 m above ground level) transparent Perspex glass platform
20 cm × 20 cm)  for 30 min  with two powerful lamps (90 cm apart)
ocusing on the rats. Non-stressed control rats were kept in their
ome cages for 30 min  before subsequent procedures. The stressed
and non-stressed) rats were subjected to electrophysiological pro-
edures or sacriﬁced after 2 h for the c-Fos study (Fig. 1A and B) as
escribed below.
.4. Surgery
One cohort of rats underwent cannula implantation surgery to
acilitate intra-NI infusion antalarmin prior to stress procedures.
rieﬂy, the rats were anaesthetised with the anaesthetic combina-
ion, ketamine (75 mg/kg) and xylazine (10 mg/kg), mounted on
 stereotaxic frame and homeothermically maintained through-
ut the aseptic procedure. Following a midline sagittal incision,
urr holes were drilled above the NI (AP: −9.7 mm and ML:  0). A
uide cannula with a dummy  stylette was lowered to a DV coordi-
ate of 7.5 mm.  The cannula was held in place with dental cement
nd anchoring skull screws. Rats were sutured, returned to the
omecage and they received analgesic and antibiotic injections
or the ﬁrst ﬁve days of the 7-day rehabilitation period. During
he experimentation, the dummy  cannula was replaced by infu-
ion cannula (with 1 mm  projection from the guide cannula) that
as connected to the microsyringe to facilitate administration of
ntalarmin hydrochloride or 0.9% saline.conﬁrming the cannula position. The inset shows a digitally zoomed version of the
boxed brainstem region.
2.5. Electrophysiology
Control and stressed rats were anaesthetised with an intraperi-
toneal injection of chloral hydrate (420 mg/kg) and mounted on
a stereotaxic frame. The lateral tail was cannulated to facilitate
administration of maintenance doses of chloral hydrate. Burr holes
were drilled to target the mPFC (AP: 3.3 mm,  ML:  ±0.8 mm  and DV:
−4.2–4.7 mm from the skull) and CA1/ventral subiculum (VS) of the
hippocampal formation (AP: −6.3, ML:  ±5.5 and DV: −4–7.2 mm
from the skull). A stainless steel monopolar electrode (SNE-300;
Kopf Instruments) with a recording tip of length 250 m and diam-
eter of 100 m was  lowered into the mPFC, and a bipolar stainless
steel stimulating electrode (SNE-100; Kopf Instruments, Tujunga,
CA, USA) with diameters of 100 and 250 m (central and outer,
respectively) and a tip separation of 500 m was  lowered into
R. Rajkumar et al. / Brain Research Bulletin 120 (2016) 83–89 85
Fig. 2. Stressors elevate c-Fos expression in the nucleus incertus. Representative images of c-Fos expression 2 h after (A) no stress condition, (B) cold swim (20 min), (C)
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owim  (30 min) and (D) elevation stresses, respectively. Scale bar: 100 m.  Dotted li
ositive cells counted over six sections (each 30 m)  sampled uniformly throughou
ne-Way ANOVA followed by Tukey’s test.
he CA1/VS. The negative going peak of the evoked response in
he mPFC due to test stimulus (250–350 A every 15 s) presenta-
ion at the CA1/VS stimulation was obtained and maximised by
ently adjusting the DV coordinates. Following the detection of
he maximal response the electrodes were left in place for 10 min
or stabilisation. An input–output curve (100–450 A) was con-
tructed for the evoked response and the stimulus intensity was
et at 60% of the maximum response for the LTP experiment. The
xperimental protocol consisted of (i) 30 min  of baseline record-
ng followed by (ii) ten trains of high-frequency stimulation (HFS;
0 pulses, 250 Hz) with inter-train interval of 10 s and ﬁnally (iii)
0 min  of post-HFS recording. Following the electrophysiological
ecordings, pontamine sky blue was infused into the NI to aid in
he postmortem veriﬁcation of the antalarmin administration site.
.6. Intra-NI infusion of antalarmin
Antalarmin hydrochloride (0.25 g/0.1 l) or an equal volume of
.9% saline was infused into the NI using the infusion cannula and
he Hamilton microsyringe assembly, over 30 s. The cannula was
eft in place for 1 min  before gradual withdrawal. The effect of anta-
armin was assessed in 2 conditions (Fig. 1B): (1) infusion 10 min
rior to elevation stress and (2) 5 min  prior to high frequency stim-
lation (post elevation stress).
.7. Postmortem processing
Rats exposed to appropriate procedures as described above
ere sacriﬁced with an overdose of pentobarbital 2 h after
resentation of stress or soon after the electrophysiological record-
ngs. Transcardial perfusion with saline (0.9%) was followed by
araformaldehyde (4% in 0.1 M phosphate buffer) and the brain
as harvested. Following post-ﬁxation in paraformaldehyde, the
rain was saturated in sucrose (30%) and subjected to cryosection-
ng to (1) detect cannula and/or electrode positions in the regions
f manipulation or (2) detect c-Fos like immunoreactivity in the
I. Animals with incorrect cannula positions were rejected from
nalysis (Fig. 1C).
.8. c-Fos Immmunoﬂuorescence labellingSix to eight serial sections (40 m)  of NI per brain sampled
hroughout the NI were blocked with goat serum and incu-
ated with anti-c-Fos primary antibody (PC38, Calbiochem, Merck)
vernight at 4 ◦C. The sections were then incubated with secondarypresent the NI, the region of interest. (E) Columns represent mean number of c-Fos
I. Error bars represent SEM. n = 4 rats. ***P < 0.001 compared to non-stressed group.
antibody Alexa Fluor 555 goat anti-rabbit (1:200; Invitrogen) and
mounted with ProLong Gold Antifade reagent with DAPI (P36935,
Molecular Probes, Invitrogen). The c-Fos immunoreactivity was
imaged with a ﬂuorescence microscope.
2.9. Counting of c-Fos positive cells
The counting of c-Fos positive cells were carried out according
to previously published procedures (Rajkumar et al., 2013; Verma
et al., 2007). Brieﬂy, the numbers of c-Fos positive NI neurons were
counted after merging with DAPI stained images of the same section
for 6–8 sections per brain. Counting was  restricted to a region of
interest, a triangular area (generated in ImageJ) that encompassed
the entire CRF1/2 receptor immunostained NI in a section where
the NI was largest in the mediolateral and dorsoventral aspects.
The values were represented by the number of c-Fos positive NI
neurons per square millimeter.
2.10. Statistics
The data from the c-Fos study was subjected to one-way ANOVA
followed by post hoc Tukey’s HSD multiple comparisons test. The
evoked potential data of 5 min  time periods of averaged ﬁeld-
evoked postsynaptic potentials (fESPs), was presented as mean
percentage ± SEM and normalized to the baseline for each group.
To demonstrate induction of LTP in the non-stressed group, a
repeated measures ANOVA for the within-subject effect of time
was conducted. To investigate treatment effects, 30 min  time peri-
ods of the same data (30 min  baseline and 0–30 min, 30–60 min
and 60–90 min  post-HFS) were subjected to two-way ANOVA with
time as a repeated measure (within subjects) and treatment groups
analysed between subjects (Lim et al., 2010). To determine the
treatment effects at various time points (TBL, T0–30, T31–60, and
T61–90) the data was subjected to two-tailed Student’s t-test (for
the comparison of different kinds of stress) or one-way ANOVA
(for antalarmin effects). All comparisons were made against the
non-stressed group. If signiﬁcance was detected in the one-way
ANOVA it was  followed by a two-tailed Student’s t-test. The alpha
value was  Bonferroni corrected for multiple comparisons. The com-
parisons were made against the same non-stressed and elevation
stress cohorts but depicted in separate plots to aid clarity.3. Results
One-way ANOVA followed by post hoc Tukey’s HSD test
showed that all the stressors signiﬁcantly [F(3,15) = 35.38, p < 0.0001]
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Fig. 3. Stressors impair HP-mPFC LTP. In the left panel (A, C, and E) data points represent mean normalised percentage ﬁeld evoked potential (fEPSP) of the preceding 5 min.
Open  circles represent the non-stressed group while light gray, dark gray and black markers represent cold swim (20 min), swim (30 min) and elevation stress groups,
respectively. The insets in the ﬁgures (A, C and E) are the representative post HFS waveforms. The broken lines represent the non-stressed group while light gray, dark
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epresent mean normalised percentage ﬁeld evoked potential (fEPSP) of preceding 
ars  represent cold swim (20 min), swim (30 min) and elevation stress groups, respe
rror  bars represent SEM. Comparison with the same non-stressed group is depicte
ncreased the number of c-Fos positive cells in the NI compared to
he non-stressed group (Fig. 2E). There was no statistically signiﬁ-
ant difference among the different stress methods.
Stimulation of the HP resulted in a characteristic negative going
aveform with a latency of 18–26 ms.  Under normal conditions
non-stressed group), HFS of the HP induced LTP and repeated
easures ANOVA indicated that the within subject effect of time
as signiﬁcant [F(24,120) = 11.546, p < 0.0001], and the amplitude of
EPSP post HFS at all the time points were signiﬁcantly higher than
he baseline ﬁeld potential. A signiﬁcant impairment in LTP was
bserved in all the stress protocols tested namely exposure to 1.
old swim for 20 min  (Fig. 3A and B), 2. swim for 30 min  (Fig. 3C
nd D) or 3. elevated platform (Fig. 3E and F). Two-way ANOVA
f the entire, 30-min averaged, data set with time as a repeated
easure and the various treatment groups (1. non-stress, 2. 20 min
old swim, 3. 30 min  swim,  4. elevation stress, 5. antalarmin before
levation stress and 6. antalarmin after elevation stress) analysed
etween subjects showed a signiﬁcant group effect [F(5,28) = 5.177,
 < 0.002].
On comparing the effects of different kinds of stress against
he non-stressed group at each of the 30-min time periods, two-
ailed Student’s t-test showed that cold swim, swim and elevation
tress signiﬁcantly (p < 0.0001) reduced the fEPSP at all time pointsoups, respectively. Scale bar: 10 ms,  0.2 mV.  In the left panel (B, D and F) columns
. Open bars represent the non-stressed group while light gray, dark gray and black
. ***P < 0.001, Repeated measures ANOVA followed by T test (Bonferroni corrected).
ree separate plots for clarity.
post HFS (Fig. 3B, D and F). Since the elevation stress showed a
robust induction of c-Fos expression in the NI and the impairment
of HP-mPFC LTP, it was selected to demonstrate that antalarmin
induced NI modulation effects on the HP-mPFC LTP. The results
indicated a signiﬁcant increase in the post HFS fEPSP amplitude
in both antalarmin treatment protocols compared to the eleva-
tion stress group (Fig. 4) showing that antalarmin infusion into
the NI reversed the elevation-stress induced reduction of post
HFS fEPSP. One-way ANOVA comparing the non-stressed, eleva-
tion stressed and antalarmin 10 min  before elevation stress groups
(Fig. 4A and B) showed signiﬁcant effects in the response to
HFS at T1–30 min [F(2,17) = 6.131, p = 0.011], T31–60 min [F(2,17) = 6.367,
p = 0.010], T61–90 min [F(2,17) = 5.567, p < 0.016]. Likewise, one-way
ANOVA comparing the non-stressed, elevation stressed and
antalarmin 5 min  before HFS groups (Fig. 4C and D) showed
signiﬁcant effects at T1–30 min [F(2,16) = 6.054, p = 0.013], T31–60 min
[F(2,16) = 7.128, p = 0.007], T61–90 min [F(2,16) = 55.761, p < 0.015]. T-
test showed that the fEPSP’s due to antalarmin treatment was
not signiﬁcantly different from the non-stressed group at all the
time points but was  signiﬁcantly lower when compared to the ele-
vation stress group [Antalarmin before elevation stress: T1–30 min,
T31–60 min, T61–90 min: p < 0.0001, antalarmin after stress before HFS:
T1–30 min: p < 0.01, T31–60 min, T61–90 min: p < 0.0001].
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Fig. 4. Antalarmin infusion into the NI reverses the effects of elevation stress-induced impairment of LTP in the HP-mPFC pathway. In the left panel, (A and C) data points
represent mean normalised percentage ﬁeld evoked potential (fEPSP) of the preceding 5 min. Open circles represent the non-stressed group while dark gray, light gray and
black  markers represent antalarmin before elevation stress, antalarmin after elevation stress and elevation stress groups, respectively. The insets in the ﬁgure (A and C) show
representative post HFS waveforms. The broken lines represent the non-stressed group, the black lines represent the elevation stress group, the dark gray line represents
antalarmin before elevation stress group (in A) while the light gray line represents the antalarmin after elevation stress group (in C). Scale bar: 10 ms, 0.2 mV. In the right
panel,  (B and D) columns represent mean normalised percentage ﬁeld evoked potential (fEPSP) of preceding 30 min. Open bars represent the non-stressed group while dark
gray,  light gray and black bars represent antalarmin before elevation stress, antalarmin after elevation stress and elevation stress groups, respectively. Error bars represent
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roup  is depicted in two  separate plots for clarity.
. Discussion
.1. Stressors elevate c-Fos expression in the NI
c-Fos induction is an accepted measure of neuronal activation
hat occurs in response to neuropsychopharmacological manip-
lations [for reviews see (Hoffman et al., 1993; Kovacs, 1998,
008)]. Acute or chronic presentation of stressors cause a brain
egion speciﬁc increase in c-Fos expression which involves mul-
iple neurotransmitter systems (Bozas et al., 1997; Kelly et al.,
011; Keshavarzy et al., 2014; Noh et al., 2012). Studies have exam-
ned the c-Fos induction in the NI in response to intra-ventricular
RF-infusion, stress presentation (Tanaka et al., 2005), exposure
o spontaneous alternation task (Ma  et al., 2009) or antipsychotic
reatments (Rajkumar et al., 2013). The abundant expression of
RF1 receptors in the NI suggests that NI could directly play a role
n stress responses and it is expected that stressors could induce
-Fos in the NI. Water immersion stress or intracerebroventricu-
ar infusion of CRF (that mimics a stress response) elevated the
-Fos expression in the NI (Tanaka et al., 2005) implying the role
f CRF1 receptors. It is apparent that all the stressors employedared to elevation stress group. Repeated measures ANOVA on the entire data set,
ferroni corrected). Comparison with the same non-stressed and elevation stressed
in the present study, caused robust increases in c-Fos expression,
suggesting that c-Fos expression in the NI may be a reliable marker
of stress response. Unlike the differential responses reported for
dorsal raphe neurons (Kelly et al., 2011), the two variants of swim
stress did not result in signiﬁcantly different magnitudes of c-Fos
induction in the NI. Given the heterogeneity of NI neurons, it will be
interesting to determine whether there is an association between
the type of stress and the subpopulation of neurons (CRF1 recep-
tor expressing, relaxin-3- or GABA-ergic) that respond. Although
there was no statistically signiﬁcant difference among the 3 kinds of
stressors employed, the exposure to the elevated platform caused
the greatest increase in the number of c-Fos positive cells of the NI.
4.2. NI contributes to stressor-related impairment of HP-mPFC
LTP
In the present study, stressors that were shown to induce c-Fos
in the NI, suppressed LTP in the HP-mPFC pathway. The HP-mPFC
pathway is especially susceptible to stress since both hippocampus
and prefrontal cortex are known to be structurally and functionally
affected by stress (Cerqueira et al., 2007; Goldwater et al., 2009).
In particular, elevation stress has been shown to suppress LTP in
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he HP-mPFC pathway (Rocher et al., 2004) and the current study
xtrapolates this ﬁnding to the two variants of swim stress.
Previous studies from our lab demonstrated that electrical stim-
lation of the NI or CRF infusion into the NI suppressed the ﬁring
f the prefrontal cortical neurons and LTP in the HP-mPFC pathway
Farooq et al., 2013). While the NI projects to both hippocampus
nd medial prefrontal cortex (Farooq et al., 2013; Goto et al., 2001;
oover and Vertes, 2007), projection neurons from the NI to the PFC
re expected to play a dominant role in the modulation of LTP in
he HP-mPFC pathway (Farooq et al., 2013). Manipulations such as
lectrical stimulation or CRF peptide infusion (CRF1 receptor acti-
ation) can be perceived as simpliﬁed, or perhaps oversimpliﬁed,
odels of stress. Now, under the presumption that stress activates
he NI via CRF1 receptor stimulation, it is reasonable to believe
hat activation of the NI in response to stress could contribute to
he suppression of HP-mPFC LTP. Hence, a direct antagonism of
RF1 receptors in the NI using antalarmin, a selective CRF1 receptor
ntagonist, was carried out to investigate if CRF1 receptor activa-
ion in the NI plays a role in stress-induced suppression of HP-mPFC
TP. Antalarmin and similar non-peptide CRF1 antagonists typically
ave 1000-fold selectivity for CRF1 receptors over CRF2 receptors
Steckler, 2015). Many studies have employed this non-peptide
RF1 antagonist (Webster et al., 1996) to elucidate the role of CRF1
eceptors in rodent stress models in which anatalarmin was  shown
o reverse stress certain responses (Banerjee et al., 2010; Djouma
t al., 2006; Forbes and Cox, 2014; Takahashi et al., 2011; Wang
t al., 2011). The dose of antalarmin was selected based on the
revious literature. Infusion of antalarmin (0.25 g) into amygdala
ecreased fear responses in stressed mice (Robison et al., 2004).
n in vivo microdialysis study in anaesthetised rats showed that
ntalarmin (0.25 g) infusion into the dorsal raphe nucleus blocked
he decrease in 5-HT levels in nucleus accumbens induced by CRF
Lukkes et al., 2008). Direct infusion of antalarmin (0.25 g) into
he dorsal raphe nucleus increased elevated plus maze open arm
ntries in isolation-reared rats (Bledsoe et al., 2011). Meanwhile,
ntracerebral infusion of a substantially higher dose of 2.1 g was
elective for CRF1 receptors over CRF2 receptors as demonstrated
y selective abolition of urocortin-evoked hypertension by pre-
reatment with this dose of antalarmin but not by pre-treatment
ith the selective CRF2 receptor anatgonist, K 41498 (Lawrence
t al., 2002).
In particular, elevation stress was selected to study the effects
f CRF1 receptor antagonism in the NI for two reasons. Firstly,
levation stress induced c-Fos expression in the NI to the great-
st magnitude among the other stressors compared in the current
tudy. Secondly, elevation stress-induced suppression of LTP was
roposed as a reliable model to study stress-induced impairments
n plasticity (Rocher et al., 2004) and this effect was reproducible in
ur laboratory. Previously, systemic pretreatment with antalarmin
as shown to reverse repetitive swim stress-induced relaxin-3
RNA expression in the NI (Banerjee et al., 2010). The suppression
f HP-mPFC LTP could involve (1) actions of CRF in the NI during
he elevation stress that have a sustained effect suppressing LTP
ater (for example involving changes in gene expression) and/or
2) effects of CRF on the activity of the NI cells during the LTP
rotocol. To differentiate between these possibilities, antalarmin
as infused directly into the NI in two separate designs: (1) 10 min
rior to elevation stress and (2) 5 min  prior to presentation of HFS.
levation stress-induced suppression of LTP was partly reversed
y intra-NI infusion of antalarmin in both treatment protocols.
hat both administration of antalarmin prior to elevation stress
nd prior to HFS (post elevation stress) partially blocked the ele-
ation stress-induced suppression of HP-mPFC LTP indicates that
oth an activation of NI during the LTP protocol and a sustained
ffect of stress are likely involved. Although the observed effects
an be attributed to the CRF1 receptors in the NI, the effects due Bulletin 120 (2016) 83–89
to diffusion of antalarmin to other structures cannot be completely
ruled out. It is tempting to speculate that under conditions of stress,
at least acute stress, CRF activates the CRF1 receptors of the NI,
which inhibit prefrontal cortical activity and thereby contribute to
impairment of plasticity in the HP-mPFC pathway.
In summary, nucleus incertus responds to stress and inﬂuences
plasticity in the HP-mPFC pathway under conditions of stress. The
liaison between HP and PFC has long been implicated in various
aspects of cognition (Eccles, 1986; Laroche et al., 2000; Spellman
et al., 2015) and plasticity in the HP-mPFC pathway has been espe-
cially useful model to study stress-related impairments (Baudin
et al., 2012; Mailliet et al., 2008; Rocher et al., 2004). The results
from the present study and those published earlier (Farooq et al.,
2013) clearly suggest that CRF receptors in the NI contribute to the
stress-induced impairment of plasticity in the HP-mPFC. It is thus
proposed that NI-HP-mPFC connectivity forms a stress responsive
ensemble in the rodent brain and that CRF1 receptor antagonism in
the NI could ameliorate stress-related impairment in cognition.
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